South Korea is facing a sharp rise in industrial technology leakage cases, with incidents increasing nearly 50% year-over-year amid growing risks of Chinese attempts to steal proprietary technologies.

Ras Al Khaimah Chamber of Commerce received a delegation from the Guangdong Provincial Department of Industry and Information Technology of the People’s Republic of China, headed by Wang Shuping, ...

The year is 2030. An “infamous mystery hacker” known as the Puppet Master is wreaking havoc on the internet, breaking into the so-called cyber-brains of several humans as well as “every terminal on ...

WeRide (NASDAQ:WRD) stock gained on Thursday as it launched its Robotaxi GXR and Robobus pilot services in partnership with the Ras Al Khaimah Transport Authority (RAKTA), marking its first deployment ...

Shell says it's developed a thermal management fluid for electric vehicles (EV) that can help speed up battery charging dramatically – we're talking 10%-80% in under 10 minutes. Not bad for an oil and ...

Nikkiso has been contracted by Shell and Freeport Oil to provide regasification and cryogenic equipment for the New Providence Gas Project in Nassau, the Bahamas. Image by Said Roldan Valiente via ...

Arrayed casually on a line of stools on a low stage at Paramount Global’s Times Square headquarters, new leadership of post-merger Paramount greeted a few dozen journalists and opened the floor, ...

The new entity, Tango Holdings, is a joint venture between Savion Equity and Ares Infrastructure Opportunities. Image: Shell/James Goldman. US renewable power developer Savion, a subsidiary of global ...

Tiberius Aerospace unveiled Sceptre, a 155mm artillery shell with an extended range. The startup's open-platform model licenses the design to governments for local production. It's an approach that ...

HOUSTON — A local professional sports venue has added new accessibility technology. Shell Energy Stadium in East Downtown is the first professional venue in North America to install the RightHear ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.